Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression
Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the difference between drug and placebo response rates is rather small (around 20%), leading to a common perception that antidepressants have limited efficacy.
AIM: The aim of the present paper was to present an alternative calculation and interpretation of antidepressant-placebo difference in the treatment response to antidepressant in drug trials which may shed a new light on the efficacy of antidepressants.
ISSUES: We have previously highlighted several controversial points concerning the calculation of antidepressant and placebo response rates in randomised controlled trials, which may influence views concerning the efficacy of drugs, and demonstrated several factors which may lead to overestimation of the placebo effect and underestimation of antidepressant efficacy. The traditional interpretation of antidepressant-placebo difference in randomized controlled trials on major depression has been also challenged previously from at least five points of view but all leading to a conclusion that currently prevailing opinions concerning relative placebo and antidepressant response rates overestimate placebo response, and thereby underestimate efficacy of antidepressant drugs. In our present paper we propose another method for calculating placebo and antidepressant response rates which may shed new light on an overlooked aspect of the efficacy of these drugs.
CONCLUSIONS: We contend that opinions on the effectiveness of antidepressants should be reconsidered, and comparisons with placebo should be more carefully applied. Interpretation of the placebo response is of crucial importance for establishing the efficacy of antidepressive medications, and psychiatry should not become the hostage of placebo.
782-786
Rihmer, Z.
3128592c-d2f0-4a5a-beaf-b5856b93f0fd
Dome, P.
c905c80a-5b50-4b2c-bb59-238c564198d3
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Gonda, X.
866afbd5-b785-4635-a1aa-7f8f864cfcde
November 2012
Rihmer, Z.
3128592c-d2f0-4a5a-beaf-b5856b93f0fd
Dome, P.
c905c80a-5b50-4b2c-bb59-238c564198d3
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Gonda, X.
866afbd5-b785-4635-a1aa-7f8f864cfcde
Rihmer, Z., Dome, P., Baldwin, D.S. and Gonda, X.
(2012)
Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
European Neuropsychopharmacology, 22 (11), .
(doi:10.1016/j.euroneuro.2012.03.002).
Abstract
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the difference between drug and placebo response rates is rather small (around 20%), leading to a common perception that antidepressants have limited efficacy.
AIM: The aim of the present paper was to present an alternative calculation and interpretation of antidepressant-placebo difference in the treatment response to antidepressant in drug trials which may shed a new light on the efficacy of antidepressants.
ISSUES: We have previously highlighted several controversial points concerning the calculation of antidepressant and placebo response rates in randomised controlled trials, which may influence views concerning the efficacy of drugs, and demonstrated several factors which may lead to overestimation of the placebo effect and underestimation of antidepressant efficacy. The traditional interpretation of antidepressant-placebo difference in randomized controlled trials on major depression has been also challenged previously from at least five points of view but all leading to a conclusion that currently prevailing opinions concerning relative placebo and antidepressant response rates overestimate placebo response, and thereby underestimate efficacy of antidepressant drugs. In our present paper we propose another method for calculating placebo and antidepressant response rates which may shed new light on an overlooked aspect of the efficacy of these drugs.
CONCLUSIONS: We contend that opinions on the effectiveness of antidepressants should be reconsidered, and comparisons with placebo should be more carefully applied. Interpretation of the placebo response is of crucial importance for establishing the efficacy of antidepressive medications, and psychiatry should not become the hostage of placebo.
This record has no associated files available for download.
More information
e-pub ahead of print date: April 2012
Published date: November 2012
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 367938
URI: http://eprints.soton.ac.uk/id/eprint/367938
ISSN: 0924-977X
PURE UUID: 2bc560d5-6a12-4ec9-b1af-59e1a332d245
Catalogue record
Date deposited: 09 Sep 2014 13:13
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
Z. Rihmer
Author:
P. Dome
Author:
X. Gonda
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics